Search

Displaying results 2931 - 2940 of 10000 in total
  1. Drug

    Sporisorium cruentum

    go.drugbank.com/drugs/DB10873
    Approved

    Sporisorium cruentum extract is used in allergenic testing.

    Mixtures: Treatment Set TS128871, Treatment Set TS329906
  2. Drug

    Lerodalcibep

    go.drugbank.com/drugs/DB19071
    ApprovedInvestigational

    [L54738] Approved by the FDA on December 15, 2025, lerodalcibep is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia … [L54738] PCSK9 is a protein that binds to and promotes the degradation of low-density lipoprotein receptors (LDLRs), which are expressed on hepatocytes regulates circulating LDL levels.

  3. Drug

    Riluzole

    go.drugbank.com/drugs/DB00740
    ApprovedInvestigational

    A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis.

    Categories: Compounds used in a research, industrial, or household settingProducts: RILUZOL - CT 50 MG, RILUTEK 50 MG
  4. Drug

    Ustilago avenae

    go.drugbank.com/drugs/DB10704
    Approved

    Ustilago avenae extract is used in allergenic testing.

    Mixtures: Treatment Set TS329906, Treatment Set TS330370
  5. Drug

    Fraxinus americana pollen

    go.drugbank.com/drugs/DB10348
    Approved

    Fraxinus americana pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS333938, Treatment Set TS128872
  6. Drug

    Lunsotogene parvec

    go.drugbank.com/drugs/DB18278
    ApprovedInvestigational

    [L56137] It acts by delivering functional copies of the human _OTOF_ gene specifically to inner hair cells via an engineered hair-cell-specific Myo15 promoter, which restores essential synaptic transmission … It is the first gene therapy to be approved under the Commissioner's National Priority Voucher (CNPV) pilot and represents one of the fastest BLA approvals in modern history, with a time between filing

  7. Drug

    Influenza A virus A/Texas/50/2012 X-223A (H3N2) hemagglutinin antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB14389
    Approved

    This defence includes the production of humoral immunity through the development of antibodies (through memory B cells) and of cell-mediated immunity through the production of T-lymphocytes. … re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus that it

    Mixtures: FluVaccinol Subunit Tetra Injektionssuspension in einer Fertigspritze
  8. Drug

    Salsola kali pollen

    go.drugbank.com/drugs/DB10388
    Approved

    Salsola kali pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS333938, Treatment Set TS128873
  9. Drug

    XEN-D0101

    go.drugbank.com/drugs/DB06020
    Experimental

    XEN-D0101 is an investigational drug developed by Xention Inc. for the treatment of Atrial Fibrillation. XEN-D0101 works by being a selective antagonist of the voltage-gated potassium channel Kv1.5.

  10. Drug

    Populus deltoides pollen

    go.drugbank.com/drugs/DB10463
    Approved

    Populus deltoides pollen is mainly used in allergenic testing.

    Mixtures: Treatment Set TS332406, Treatment Set TS332229